Institutional Ownership Zynerba Pharmaceuticals, Inc. (ZYNE)
This table provides information about the institutional ownership of Zynerba Pharmaceuticals, Inc. (ZYNE). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 773,991 shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
723,151
shares
|
$0
0.01% of portfolio
|
Q1 2023
Reduced 52.14%
|
|
|
Zeke Capital Advisors, LLC
Berwyn, PA |
Feb 14, 2023 Q4 2022 |
49,700
shares
|
$0
0.0% of portfolio
|
Q3 2020
Reduced 88.76%
|
|
|
Ahrens Investment Partners LLC
|
Apr 21, 2023 Q1 2023 |
1,040
shares
|
$0
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Kistler Tiffany Companies, LLC
Berwyn, PA |
Aug 01, 2023 Q2 2023 |
100
shares
|
$0
0.0% of portfolio
|
Q3 2017
New holding
|